BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim EY, Shotorbani PY, Dryer SE. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Biochem Biophys Rep 2019;17:139-50. [PMID: 30662960 DOI: 10.1016/j.bbrep.2018.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim EY, Dryer SE. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats. Cells 2022;11:1985. [DOI: 10.3390/cells11131985] [Reference Citation Analysis]
2 Han Z, Ma K, Tao H, Liu H, Zhang J, Sai X, Li Y, Chi M, Nian Q, Song L, Liu C. A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives. Front Immunol 2022;13:826732. [PMID: 35251009 DOI: 10.3389/fimmu.2022.826732] [Reference Citation Analysis]
3 Khayyat NH, Tomilin VN, Zaika O, Pochynyuk O. Polymodal roles of TRPC3 channel in the kidney. Channels (Austin) 2020;14:257-67. [PMID: 32787494 DOI: 10.1080/19336950.2020.1804153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim EY, Dryer SE. Effects of TRPC6 Inactivation on Glomerulosclerosis and Renal Fibrosis in Aging Rats. Cells 2021;10:856. [PMID: 33918778 DOI: 10.3390/cells10040856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hall G, Wang L, Spurney RF. TRPC Channels in Proteinuric Kidney Diseases. Cells 2019;9:E44. [PMID: 31877991 DOI: 10.3390/cells9010044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
6 Hassanzadeh Khayyat N, Kim EY, Dryer SE. TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats. FASEB Bioadv 2019;1:773-82. [PMID: 32123821 DOI: 10.1096/fba.2019-00077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Talbot BE, Vandorpe DH, Stotter BR, Alper SL, Schlondorff JS. Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6. J Biol Chem 2019;294:12655-69. [PMID: 31266804 DOI: 10.1074/jbc.RA119.008299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Staruschenko A, Spires D, Palygin O. Role of TRPC6 in Progression of Diabetic Kidney Disease. Curr Hypertens Rep 2019;21:48. [PMID: 31115705 DOI: 10.1007/s11906-019-0960-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
9 Kopp JB, Heymann J. c-Src is in the effector pathway linking uPAR and podocyte injury. J Clin Invest 2019;129:1827-9. [PMID: 30939121 DOI: 10.1172/JCI127927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]